HIKMA PHARMACEUTIC.LS-,10 financial statements, including revenue, expenses, profit, and loss

The total revenue of H5P for the last semiannual is 1.33 B EUR, and it's 1.02% lower compared to the previous semiannual. The net income of H2 23 is 54.31 M EUR.